# Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration

> **NCT00777374** · PHASE2 · COMPLETED · sponsor: **University of Zurich** · enrollment: 97 (actual)

## Conditions studied

- Allergic Rhinoconjunctivitis

## Interventions

- **DRUG:** Patch
- **DRUG:** Placebo patch

## Key facts

- **NCT ID:** NCT00777374
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2011-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00777374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00777374, "Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00777374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*